NCT03503383

Brief Summary

This study is a case controlled study comparing mental health status and some psychological impacts between two groups of patients first group is pregnant women without any other medical disorder during pregnancy,the second group is pregnant women complaining of hypertension with pregnancy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2018

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2018

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

March 26, 2018

Completed
24 days until next milestone

First Posted

Study publicly available on registry

April 19, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

April 19, 2018

Status Verified

April 1, 2018

Enrollment Period

7 months

First QC Date

March 26, 2018

Last Update Submit

April 18, 2018

Conditions

Keywords

Hypertension with pregnancyanxietydepressionpreeclampsiamental health

Outcome Measures

Primary Outcomes (2)

  • Depression Evaluation using Patient Health Questionnaire-9 (PHQ-9)

    Patient Health Questionnaire-9 is used to assess number of participants with depression.

    6 months

  • Anxiety Evaluation using Generalized Anxiety Disorder Scale-7 (GAD-7)

    Generalized Anxiety Disorder Scale (GAD-7) is used to assess number of participants with anxiety disorders.

    6 months

Study Arms (2)

Controlled group

pregnant women without any medical disorders during pregnancy

Behavioral: Patient Health Questionnaire-9Behavioral: Generalized Anxiety Disorder Scale (GAD-7)

Diseased group

Patients complaining of hypertension with pregnancy

Behavioral: Patient Health Questionnaire-9Behavioral: Generalized Anxiety Disorder Scale (GAD-7)

Interventions

PHQ-9 for assessing and monitoring depression severity

Also known as: PHQ-9 depression scale
Controlled groupDiseased group

to diagnose generalized anxiety disorder, the GAD-7 also proved to have good sensitivity and specificity as a screener for panic, social anxiety, and post-traumatic stress disorder

Also known as: GAD-7
Controlled groupDiseased group

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThis study only includes pregnant women
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

This study is comparing between two groups, first group is healthy pregnant women and second group is pregnant women with hypertension . Both groups are assessed for both Anxiety and Depresion disorders.

You may qualify if:

  • pregnant women
  • Hypertensive pregnant women for diseased group
  • Normal pregnancy with no medical disorders associated in controlled group
  • singleton pregnancy
  • spontaneous pregnancy
  • patients who are not divorced or not widow

You may not qualify if:

  • non-pregnant women
  • any other associated medical disorder with pregnancy rather than Hypertension
  • any known psychological or mental disorder prior to pregnancy
  • non spontaneous pregnancy as those whom conceived by IVF
  • Twin or more pregnancy
  • patients who are divorced or widow

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Minya Health Insurance Hospital

Minya, 61111, Egypt

RECRUITING

Zagazig University Hospitals

Zagazig, Egypt

RECRUITING

MeSH Terms

Conditions

Anxiety DisordersDepressionPre-EclampsiaPsychological Well-Being

Interventions

Patient Health Questionnaire

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehaviorHypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPersonal Satisfaction

Intervention Hierarchy (Ancestors)

Surveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesPsychological TestsBehavioral Disciplines and ActivitiesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Mena M Abdalla, MSc

    Zagazig University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mena M Abdalla, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
4 Weeks
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 26, 2018

First Posted

April 19, 2018

Study Start

March 1, 2018

Primary Completion

October 1, 2018

Study Completion

December 1, 2018

Last Updated

April 19, 2018

Record last verified: 2018-04

Locations